-
Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and RegistriesH Gonzales, PS Douglas, BR Lindman et al. -
2020 ACC Expert Consensus Decision Pathway on Management of Conduction Disturbances in Patients Undergoing Transcatheter Aortic Valve Replacement A Report of the American College of Cardiology Solution Set Oversight CommitteeWriting Committee, SM Lilly, AJ Deshmukh et al.
-
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II SurveyB Iung , V Delgado ,the EORP VHD II Investigators.
-
Ascending Aortic Length and Risk of Aortic Adverse Events: The Neglected DimensionJ Wu, MA Zafar, Yupeng Li, JA Elefteriades et al.
-
Infective Endocarditis After Transcatheter Aortic Valve ReplacementS Stortecky, D Heg, D Tueller, T Pilgrim et al.
-
Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve ReplacementD del Val, M Abdel-Wahab, J Rodés-Cabau et al.
-
Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT IITM Nazif, J Moses, REFLECT II Trial Investigators et al.
-
Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve ReplacementA Mentias, M Saad, S Girotra et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
